<DOC>
	<DOCNO>NCT01167101</DOCNO>
	<brief_summary>Treatment strategy post endoscopic submucosal dissection ( ESD ) ulcer yet conclusive . Rebamipide mucosal protective agent widely use East Asia good effect quality ulcer healing ( QOUH ) . The investigator conduct randomize control study ass effect combination therapy rebamipide proton pump inhibitor ( PPI ) post ESD ulcer healing .</brief_summary>
	<brief_title>Is Rebamipide Effective Healing Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection ?</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>patient underwent ESD gastric adenoma cancer subject previous gastric surgery subject take aspirin , anticoagulant , antiplatelet agent subject malignancy except gastric cancer pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Rebamipide</keyword>
	<keyword>gastric ulcer</keyword>
	<keyword>heal rate</keyword>
	<keyword>iatrogenic gastric ulcer endoscopic submucosal dissection</keyword>
</DOC>